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ABSTRACT 
ZIP14 (encoded by the solute carrier 39 family 
member 14 [SLC39A14] gene) is a manganese (Mn) 
transporter that is abundantly expressed in the liver 
and small intestine. Loss-of-function mutations in 
SLC39A14 cause severe hypermanganesemia. As 
the liver is regarded as the main regulatory organ 
involved in Mn homeostasis, impaired hepatic Mn 
uptake for subsequent biliary excretion has been 
proposed as the underlying disease mechanism. 
However, liver-specific Zip14 knock-out (KO) 
mice exhibit decreased Mn only in the liver, and do 
not develop Mn accumulation in other tissues under 
normal conditions. This suggests that impaired 
hepatobiliary excretion is not the primary cause for 
Mn overload observed in individuals lacking 
functional ZIP14. We therefore hypothesized that 
increased intestinal Mn absorption could induce Mn 
hyperaccumulation when ZIP14 is inactivated. To 
elucidate the role of ZIP14 in Mn absorption, here 
we used CaCo-2 transwell cultures as a model 
system for intestinal epithelia. The generation of a 
ZIP14-deficient CaCo-2 cell line enabled the 
identification of ZIP14 as the major transporter 
mediating basolateral Mn uptake in enterocytes. 
Lack of ZIP14 severely impaired basolateral-to-
apical (secretory) Mn transport and strongly 
enhanced Mn transport in the apical-to-basolateral 
(absorptive) direction. Mechanistic studies 
provided evidence that ZIP14 restricts Mn transport 
in the absorptive direction via direct basolateral 
reuptake of freshly absorbed Mn. In support of such 
function of intestinal ZIP14 in vivo, Mn levels in 
the livers and brains of intestine-specific Zip14-KO 
mice were significantly elevated. Our findings 
highlight the importance of intestinal ZIP14 in 
regulating systemic Mn homeostasis. 
 
Mn is an essential nutrient. As a cofactor for 
several enzymes, it is required for the normal 
function of several physiologic processes including 
protein glycosylation, detoxification of superoxide 
and ammonia, and gluconeogenesis (1,2). 
Excessive Mn accumulation, however, leads to 
manganism, whose symptoms resemble those of 
Parkinson’s disease (1). Therefore, Mn homeostasis 
must be tightly controlled at the systemic and 
cellular levels. 
Systemic Mn homeostasis is maintained by 
intestinal Mn absorption and hepatobiliary Mn 
excretion (3-6). Oral exposure is the major source 
of Mn absorption with about 2-3% of Mn being 
absorbed from a diet adequate in Mn (7). For 
dietary Mn intakes that are in the physiologic range, 
oral Mn absorption appears to be primarily 
controlled by varying intestinal absorption rates (8). 
However, biliary Mn elimination becomes the main 
homeostatic mechanism when intestinal control 
mechanisms are overwhelmed or bypassed, e.g. by 
intravenous injection or inhalation exposure.  
On a cellular level, the distribution of Mn 
involves mechanisms for entry and exit as well as 
specific pathways that ensure intracellular transport 
and targeting. To date, these mechanisms remain 
poorly defined. Components of the iron (Fe) 
metabolic pathways, citrate-, choline-, dopamine-, 
and calcium-transporters, the sodium-calcium 
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exchanger as well as the ATPases Park9 and 
SPCA1 have been implicated in Mn metabolism 
(9). More recently, spurred by the discovery of 
human mutations, members of the ZnT- and ZIP-
families of metal transporters, namely ZnT10, ZIP8 
and ZIP14 have been identified as crucial players in 
cellular Mn metabolism in vivo (10-14). 
Previous studies have shown that ZIP14 is 
capable of mediating the uptake of Mn in vitro (15). 
Highlighting the function of ZIP14 as a Mn 
transporter in vivo, homozygous mutations of 
ZIP14 result in Mn hyperaccumulation in the blood 
and other tissues of affected individuals without 
apparent effects on other metals (10,16-18). 
Initially it was postulated that the primary function 
of ZIP14 is hepatic Mn uptake for subsequent 
biliary excretion and that the Mn 
hyperaccumulation observed in other tissues is 
secondary to the defect of hepatic ZIP14 (10). The 
latter hypothesis, however, was falsified by 
experiments involving a liver-specific Zip14 KO 
mouse line (19). Specifically, these mice did not 
display elevated Mn in the blood or other tissues in 
contrast to global Zip14 KO mouse models, 
although ZIP14 has been clearly demonstrated to be 
required for hepatobiliary Mn excretion under high 
Mn conditions (19-22).  
ZIP14 is also highly abundant in the small 
intestine of humans and mice (23,24). We 
hypothesize that, if not impaired hepatobiliary 
excretion, increased intestinal Mn absorption could 
be the primary cause for the Mn hyperaccumulation 
observed in individuals lacking functional ZIP14. 
To test our hypothesis, we generated a CaCo-2 cell 
line with ZIP14 inactivation (CaCo-2DZIP14 cells). 
Differentiated monolayers of this cell line exhibited 
a dramatic defect in basolateral Mn uptake. Apical- 
to-basolateral Mn transport in CaCo-2DZIP14 cells 
was strongly increased compared to that of wild 
type CaCo-2 (CaCo-2WT) cells. Further mechanistic 
studies provided evidence that ZIP14 controls 
enterocyte Mn absorption by mediating basolateral 
reuptake of freshly absorbed Mn. To evaluate the 
physiologic relevance of this novel homeostatic 
mechanism, we generated intestine-specific Zip14 
KO mice. These mice developed markedly 
increased Mn levels in their livers and brains. 
Overall, our results suggest an important function 
of intestinal ZIP14 in the control of systemic Mn 
homeostasis. 
Results 
Generation of a ZIP14 KO CaCo-2 cell line  
To assess the function of ZIP14 in enterocytes 
we inactivated the ZIP14 gene in CaCo-2 cells via 
CRISPR/Cas9-mediated gene KO by targeting the 
start codon in exon 2 of ZIP14 (Fig. 1A). CaCo-2 
cells differentiate spontaneously into polarized 
enterocytes when grown on permeable filter 
supports (25). Such CaCo-2 cell cultures provide a 
well-established model system to study the uptake 
as well as absorptive (apical-to-basolateral 
direction) and secretory (basolateral-to-apical 
direction) fluxes of drugs and nutrients in the 
intestinal epithelium. This model has been 
extensively used to study the mechanisms of 
intestinal Fe-uptake and -transport. In general, 
results from Fe absorption studies conducted in 
vitro using CaCo-2 cells correlate well with 
observations made in vivo (26), validating the use 
of the CaCo-2 cell model for studying intestinal 
metal uptake and transport. 
By using the CRISPR/Cas9 approach, we 
isolated a CaCo-2 cell clone termed CaCo-2DZIP14 
with a single base pair insertion at the predicted 
Cas9-cleavage site (Fig. 1B). This insertion caused 
a frame shift mutation, yielding a non-functional 
protein that consists of only 26 amino acids (Fig. 
1C). Immunoblot analysis confirmed the 
inactivation of ZIP14 in CaCo-2DZIP14 cells (Fig. 1D 
and Fig. S1). 
Characterization of CaCo-2WT and CaCo-2DZIP14 
transwell cultures 
In order to study Mn transport across the 
intestinal epithelium and the role of ZIP14 in this 
process, both CaCo-2WT and CaCo-2DZIP14 cells 
were grown into differentiated monolayers for at 
least 21 days. The presence of polarized 
monolayers was confirmed by confocal microscopy 
using the tight junction protein ZO-1 as the apical 
marker and Na+, K+-ATPase as the basolateral 
marker (Fig. 2A). Further analysis of these images 
revealed diameters of 11 µm and 9 µm and heights 
of 12 µm and 19 µm for CaCo-2WT cells and CaCo-
2DZIP14 cells, respectively. The consequential larger 
basolateral and apical surface areas and volumes of 
CaCo-2DZIP14 transwell cultures, which we 
estimated to be about 180% and 150% of equivalent 
CaCo-2WT cultures, are mirrored by a similar 
increase in the protein contents of these cultures 
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(Fig. 2B). Thus, to compensate for the increased 
surface, we normalized our uptake- and transport-
data to the protein content in the respective 
transwell insert. The integrity of the monolayers 
was tested by the Lucifer Yellow (LY) rejection 
assay. Apparent LY permeability (Papp) coefficients 
below 10 nm x s-1 have been reported to be 
indicative of well-established CaCo-2 monolayers 
(27). Papp coefficients determined for both CaCo-
2WT and CaCo-2DZIP14 monolayers fell in that range 
but were significantly higher in CaCo-2DZIP14 
transwell cultures (Fig. 2C). Due to the smaller 
diameter of CaCo-2DZIP14 cells, CaCo-2DZIP14 
transwell cultures possess a greater number of 
paracellular pores, the sites of paracellular 
transport, which may partially account for the 
increased permeability of LY. Consequently, when 
normalized to protein, Papp did not differ 
significantly between the cultures.  
Deletion of Zip14 in mice does not affect the 
intestinal contents of Mn, zinc (Zn), Fe and copper 
(Cu) (19). To test whether this observation is 
reflected in the CaCo-2-transwell system, we 
measured their specific contents by inductively 
coupled plasma mass spectrometry (ICP-MS). We 
found the specific contents of Mn, Zn and Fe in 
CaCo-2DZIP14 monolayers to be significantly lower 
compared to those in CaCo-2WT cells (Fig. 2D). We 
ascribe this discrepancy to the in vivo situation to 
limitations of our transwell system. In vivo 
enterocytes can acquire nutrients from both the 
intestinal lumen and the arterial blood. Transporters 
functioning in metal uptake from the luminal side 
of the proximal intestine, such as DMT1, are 
optimally adjusted to the acidic milieu of the 
intestinal tract (28-30). In the transwell system, 
however, the pH in the apical chamber is 
maintained at 7.4 during regular culturing, 
impairing efficient metal uptake from this side.  
To confirm previous results on the localization 
of ZIP14 in enterocytes (21,31) we studied the 
localization of ZIP14 in polarized CaCo-2WT 
monolayers. Basolateral and apical surface proteins 
were isolated by a biotinylation approach. 
Immunoblotting for ZIP14 demonstrated the 
enrichment of ZIP14 at the basolateral membrane 
of CaCo-2WT cells (Fig. 2E and Fig. S2). This 
localization of ZIP14 in enterocytes supports a role 
of ZIP14 in the uptake of Mn from the blood. 
ZIP14 is the major transporter responsible for Mn 
uptake at the basolateral membrane 
To establish the function of ZIP14 in the Mn 
metabolism of enterocytes, we first studied the 
consequences of ZIP14 KO on basolateral 54Mn 
accumulation. If not stated otherwise, during the 
experiments the extracellular pH was maintained at 
6.1 in the apical and 7.4 in the basolateral 
compartment to mimic the physiologic situation, 
i.e. the acidic intraluminal pH of the proximal small 
intestine and the normal blood pH. Upon addition 
of 0.1 µM 54Mn, which is close to the low Mn 
concentrations in mammalian serum [0.01 µM - 
0.04 µM; (32)] to the basolateral chamber, CaCo-
2WT cells rapidly accumulated 54Mn up to 180 
minutes after which cellular 54Mn contents had 
reached a steady state (Fig. 3A). Basolateral 54Mn 
accumulation by CaCo-2DZIP14 cells was severely 
compromised, identifying ZIP14 as the primary 
transporter mediating Mn uptake at the basolateral 
membrane of CaCo-2 cells. The residual basolateral 
54Mn accumulation observed in CaCo-2DZIP14 cells 
suggests the presence of an alternative, low-
capacity entry route for Mn at the basolateral 
membrane.  
Next we examined the pH dependence of 
basolateral Mn accumulation by measuring the 
amount of 54Mn accumulated by CaCo-2 cells 
incubated in media at pH 6.1, pH 6.8 or pH 7.4 for 
4 h. These experiments were performed by 
adjusting the incubation media to the same pH in 
both the basolateral and apical compartments. 
Basolateral 54Mn accumulation by CaCo-2WT cells 
was maximal at pH 7.4 and decreased with 
decreasing pH (Fig. 3B). While CaCo-2WT cells still 
accumulated substantial amounts of 54Mn at pH 6.8, 
the basolateral 54Mn accumulation in these cells 
decreased by about 90% at pH 6.1. Consistent with 
ZIP14 being the major transporter mediating Mn 
uptake at the basolateral membrane of CaCo-2WT 
cells, similar pH dependencies have been reported 
for ZIP14-mediated Fe and Zn transport (33,34). 
Opposite to what we observed for CaCo-2WT cells, 
basolateral 54Mn accumulation by CaCo-2DZIP14 
cells was maximal at pH 6.1 and lower at pH 6.8 
and 7.4.  
ZIP14 deletion does not substantially affect apical 
Mn uptake 
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 In contrast to the striking effect of ZIP14 KO 
observed for basolateral 54Mn accumulation, 54Mn 
accumulation from the apical chamber was 
observed to be rather similar in both cell lines. 
Within 6 h both CaCo-2WT and CaCo-2DZIP14 cells 
accumulated about 30 pmol x mg-1 54Mn from the 
apical chamber (Fig. 3C). While apical 54Mn-
accumulation by CaCo-2DZIP14 cells proceeded at 
slightly faster pace between 30 minutes and 3 h of 
incubation, 54Mn contents in CaCo-2DZIP14 cells 
approached a steady state thereafter whereas 54Mn 
contents in CaCo-2WT cells continued to rise at 
almost constant speed for up to 6 h. Mn 
accumulation by CaCo-2 cells is a complex process 
involving the uptake and export of Mn at the apical 
side, its intracellular sequestration and transport, as 
well as its basolateral uptake and export. The 
accelerated accumulation of 54Mn from the apical 
side by CaCo-2DZIP14 cells compared to CaCo-2WT 
cells between 30 minutes and 3 h may therefore be 
explained by several mechanisms, including a 
ZIP14-dependent export process of freshly 
acquired Mn (either at the basolateral or apical side) 
that is activated when cellular Mn levels rise above 
a certain threshold. 
Apical 54Mn accumulation exhibited the same 
dependence on the extracellular pH in both CaCo-
2WT and CaCo-2DZIP14 cells, being maximal at pH 
6.1 and decreasing with increasing pH (Fig. 3D). 
While this is relevant under physiological 
conditions as the pH in the proximal intestine is 
rather acidic, the mechanisms mediating Mn uptake 
from the intestinal lumen remain unknown. DMT-
1, which is strongly expressed at the intestinal brush 
border (35) and at the apical membrane of CaCo-2 
cells (Fig. 2E), had long been regarded as a 
potential candidate. However, recently Shawki et 
al. (36) reported that DMT-1 is not required for Mn 
absorption in intestine-specific Dmt-1 KO mice, 
contrasting previous observations made in the 
Belgrade rat model (37,38). 
ZIP14 restricts Mn absorption 
Having established that ZIP14 is the major 
transporter mediating basolateral Mn uptake and 
that ZIP14 deletion does not substantially affect Mn 
uptake from the apical membrane of CaCo-2 cells, 
we next investigated the transport of Mn across 
CaCo-2 cell monolayers in both basolateral-to-
apical and apical-to-basolateral directions. Upon 
application of 0.1 µM 54Mn to the basolateral side 
of CaCo-2WT cells, the amounts of 54Mn detected in 
the apical chamber rapidly increased with time (Fig. 
4A). Following an exponential phase that lasted 
about 90 minutes, the amounts of 54Mn on the apical 
side increased almost linearly for up to 240 
minutes. In contrast, CaCo-2DZIP14 cells transported 
only minimal amounts of 54Mn from the basolateral 
to apical compartment within 240 minutes. This 
result could be expected since CaCo-2DZIP14 cells 
lack substantial basolateral Mn uptake activity. 
After addition of 0.1 µM 54Mn to the apical 
chamber to initiate the apical-to-basolateral 
transport, we observed a slow, exponential rise in 
the amounts of 54Mn detected in the apical chamber 
in the first 150 minutes followed by a linear 
increase for up to 240 minutes for CaCo-2WT cells 
(Fig. 4B). The time dependence of apical-to-
basolateral Mn transport by CaCo-2DZIP14 cells 
displayed a similar pattern but with significantly 
higher amounts of 54Mn accumulated in the 
basolateral compartment. The increased apical-to-
basolateral Mn transport by CaCo-2DZIP14 cells 
compared to CaCo2WT cells strongly suggests that 
intestinal ZIP14 is required to restrict Mn 
absorption. 
ZIP14 has been described as a broad-scope 
metal transporter, capable of mediating the cellular 
uptake of several metals including Fe (33,34). 
Hence, we tested the consequences of ZIP14 
deletion on Fe accumulation and transport in CaCo-
2 cell monolayers upon addition of 1 µM 59Fe2+ or 
59Fe3+. Consistent with the function of ZIP14 as a 
Fe2+-transporter, basolateral 59Fe2+ accumulation 
was lowered by 30% in CaCo-2DZIP14 cells, whereas 
59Fe3+ accumulation did not differ significantly 
from CaCo-2WT cells (Fig. S3A). In contrast to Mn 
transport, the lack of ZIP14 did not affect the 
apical-to-basolateral transport of 59Fe2+ and 59Fe3+ 
(Fig. S3C, D), most likely since Fe is released from 
the cells into the media in its ferric state. This result 
suggests that in the CaCo-2 transwell system, 
functional ZIP14 specifically restricts Mn 
absorption.  
ZIP14 mediates Mn reuptake from the basolateral 
membrane to restrict Mn absorption 
In CaCo-2 cells, ZIP14 restricts the flux of Mn 
in the absorptive direction (Fig. 4B), but how is it 
accomplished? ZIP14 is localized to the basolateral 
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membrane of CaCo-2 cells (Fig. 2E) and is required 
for efficient Mn uptake from the basolateral side 
(Fig. 3A, B). Accordingly, direct reuptake of 
freshly absorbed Mn is a plausible mechanism by 
which ZIP14 may restrict Mn absorption. If so, 
inhibiting basolateral Mn uptake should increase 
apical-to-basolateral Mn transport in CaCo-2WT 
cells, but not in CaCo-2DZIP14 cells. We used three 
approaches to minimize basolateral Mn reuptake. 
First, since ZIP14-mediated 54Mn uptake is 
highest at pH 7.4 and decreases by 95% at pH 6.1 
(Fig. 3B), we studied the transport of 0.1 µM 54Mn 
from the apical to basolateral compartment with the 
pH in the basolateral chamber being maintained at 
pH 7.4 as the normal condition or adjusted to pH 
6.1. For CaCo-2WT cells 54Mn accumulation in the 
basolateral chamber was found to be about five 
times higher at a basolateral pH of 6.1 compared to 
a basolateral pH of 7.4 (Fig. 5A). In contrast, 
apical-to-basolateral Mn transport by CaCo-2DZIP14 
cells slightly decreased with lowering the 
basolateral pH from pH 7.4 to pH 6.1 (Fig. 5B). 
These observations are consistent with the pH 
dependence of basolateral Mn accumulation (Fig. 
3B), and suggest that Mn transport in the apical-to-
basolateral direction is limited by basolateral Mn 
uptake. 
Apical-to-basolateral Mn transport requires 
about 150 minutes to become fully established (Fig. 
4B). To exclude that the modulation of basolateral 
mediated Mn uptake by altering the basolateral pH 
induces changes in the recruitment of transporters 
required for the export of intracellular Mn at the 
basolateral side, we removed 54Mn from the apical 
compartment after 4 h of 54Mn preloading and 
followed 54Mn accumulation in the basolateral 
compartment for another 3 h, with the pH of the 
basolateral compartment either maintained at the 
same pH as in the first 4 h, or switched to pH 6.1 or 
pH 7.4 (Fig. 5C, D, E, F). Alteration of the 
basolateral pH caused a rapid response in the 
apical-to-basolateral transport rates. The immediate 
effect of the basolateral pH switch on the apical-to-
basolateral Mn transport in CaCo-2 cells, suggests 
that the elevated Mn absorption at lower pH 
observed in CaCo-2WT cells is indeed due to 
impaired ZIP14 mediated Mn uptake at low pH 
rather than due to alterations in transporter 
abundance at the basolateral membrane. 
Second, we used excess Zn to compete with 
54Mn reuptake from the basolateral chamber. Zn has 
previously been reported as a potent competitive 
inhibitor of ZIP14-mediated Mn uptake (33). 
However, initial experiments revealed that a ten-
times excess of Zn does not inhibit basolateral 54Mn 
accumulation by CaCo-2WT cells when Dulbecco’s 
modified Eagles medium (DMEM) was used as the 
experimental medium (Fig. S4A). In contrast, when 
salt-based incubation buffer was used instead of 
DMEM, excess Zn strongly impaired basolateral 
54Mn accumulation in CaCo-2WT cells (Fig. S4B). 
Thus, to study the effect of Zn on apical-to-
basolateral transport CaCo-2 monolayers were first 
loaded for 4 h with 0.1 µM 54Mn from the apical 
side, after which the accumulation of 54Mn in the 
basolateral compartment was followed for 90 
minutes using salt-based incubation buffer with or 
without 2 µM Zn. The presence of 2 µM Zn 
strongly enhanced 54Mn accumulation in the 
basolateral compartment of CaCo-2WT transwell 
cultures (Fig. 6A), suggesting that Zn impairs the 
direct reuptake of freshly absorbed Mn by 
competing with 54Mn for uptake via ZIP14. 
Consistent with this view, 54Mn accumulation in the 
basolateral compartment of CaCo-2DZIP14 transwell 
cultures (Fig. 6B) was not altered by Zn. 
Third, we sought to prevent ZIP14-mediated 
Mn reuptake by chelating freshly absorbed Mn with 
EDTA or desferrioxamine (DFO), which are strong 
chelators for Mn(II) and Mn(III), respectively 
(39,40). Since both EDTA and DFO are membrane 
impermeable (41), the intracellular Mn trafficking 
would not be disturbed. To carry out the 
experiment, CaCo-2 monolayers were first loaded 
for 4 h with 0.1 µM 54Mn from the apical side, after 
which the accumulation of 54Mn in the basolateral 
compartment was followed for 90 minutes using 
salt-based incubation buffer containing either no 
chelator, 100 µM CaNa2EDTA or 1 mM DFO. The 
presence of both EDTA or DFO caused an 
increased accumulation of 54Mn in the basolateral 
compartment of CaCo-2WT transwell cultures (Fig. 
6C and E) but not in CaCo-2DZIP14 transwell cultures 
(Fig. 6D and F). As Mn is released close to the 
plasma membrane, the moderate effect of both 
chelators on the accumulation of 54Mn in the 
basolateral compartment of CaCo-2WT transwell 
cultures is most likely due to limited access of 
EDTA and DFO to Mn prior to its reuptake. 
Nevertheless, these results further support our 
proposed mechanism that ZIP14 restricts Mn 
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absorption by direct reuptake of freshly absorbed 
Mn. 
Intestine-specific deletion of Zip14 in mice leads 
to Mn overload 
To test the physiologic relevance of our 
findings, we generated mice carrying Zip14 
conditional alleles (Zip14flox/flox mice) by flanking 
exon 3 and 4 of the Zip14 with loxP sites (Fig. 7A). 
The correct insertion of loxP sites was verified by 
genotyping (Fig. 7B). We then generated intestine-
specific Zip14 KO mice by crossing Zip14flox/flox 
mice with Vil-Cre mice. For comparison, we also 
generated liver-specific Zip14 KO mice. Tissue-
specific inactivation of Zip14 was confirmed by 
immunoblot analysis (Fig. 7C and Fig. S5).  
We used ICP-MS to determine Mn levels in 
whole blood, livers and brains from Zip14flox/flox 
mice, intestine-specific, and liver-specific Zip14 
KO mice at three weeks of age. We observed a clear 
difference in the hepatic Mn levels from liver-
specific Zip14 KO mice and intestine-specific 
Zip14 KO mice (Fig. 7D): consistent with previous 
results (19), hepatic Mn contents were significantly 
reduced in liver-specific Zip14 KO mice; in 
contrast, Mn levels in livers from intestine-specific 
Zip14 KO mice were more than two times that of 
controls, revealing that loss of ZIP14 in the 
intestine increases body Mn burden. This 
observation establishes the importance of the 
intestinal ZIP14 in the control of systemic Mn 
homeostasis, and is in full agreement with our 
discovery that deletion of ZIP14 in CaCo-2 cells 
results in increased apical-to-basolateral Mn 
transport. 
Although Mn concentrations in the blood of 
intestine-specific Zip14 KO mice did not increase 
(Fig. 7D), brain Mn contents were double that of 
control and liver-specific Zip14 KO mice at three-
week old. An explanation could be that Mn 
homeostasis can still be regulated through 
hepatobiliary excretion in intestine-specific Zip14 
KO mice, but the liver cannot clear all of the excess 
Mn entering the portal blood, and elevated Mn 
entering the systemic circulation are readily 
absorbed by other tissues, including the brain. 
Further studies are required to evaluate the Mn 
contents in other tissues of intestine-specific Zip14 
KO mice and to examine the consequences of Zip14 
deletion in both the liver and intestine. 
Discussion 
In the present study, we identified ZIP14 as the 
major transporter mediating basolateral Mn uptake 
in enterocytes. Moreover, we provide in vitro and 
in vivo evidence that this function of ZIP14 is 
required for the control of Mn homeostasis. 
CaCo-2 cell cultures provide a well-established 
model system to study the uptake as well as 
absorptive and secretory fluxes of drugs and 
nutrients in the intestinal epithelium (25). 
Genetically modified Caco-2 cell lines have 
previously been used to study the uptake and 
transport of metals. Just recently, a stable CaCo-2 
cell line over-expressing ZnT10 has been employed 
to prove the ability of this transporter to mediate the 
efflux of cellular Mn at the apical membrane (52). 
RNA interference (RNAi)-mediated gene 
knockdown has been used to study the functions of 
ZnT1, ferroportin and DMT1 in CaCo-2 cell 
monolayers (42,43). A drawback of RNAi-
mediated gene knock-down is the possibility of 
residual gene expression that may mask potential 
phenotypes, a complication that we avoided by 
generating a ZIP14 KO CaCo-2 cell line using the 
CRISPR/Cas9 system.   
In contrast to previous studies investigating Mn 
uptake and Mn transport by CaCo-2 cells (44-46), 
we maintained a pH of 6.1 in the apical and a pH of 
7.4 in the basolateral compartment to mimic the 
physiologic situation. Such pH gradient is routinely 
used in studies investigating Fe uptake and Fe 
transport in CaCo-2 cells, and is of uttermost 
importance when studying apical Mn uptake and 
apical-to-basolateral Mn transport as substantial 
Mn transport in the absorptive direction occurs only 
at acidic apical pH (Fig. S6). To account for the low 
Mn concentrations in mammalian serum [0.01 µM 
- 0.04 µM; (32)], breast milk [0.004 µM - 0.55 µM; 
(47)] and infant formulas[0.73 µM - 20 µM; (48)] 
we used a concentration of 0.1 µM Mn as our 
standard concentration, whereas non-physiologic 
high Mn concentrations of 30 µM to 146 µM were 
employed in the previous studies (44-46).  
Systemic Mn homeostasis is maintained by the 
regulation of both intestinal Mn absorption and 
hepatobiliary Mn excretion (3-6). The 
accumulation of excess Mn in blood and several 
organs in individuals with homozygous mutations 
in ZIP14 (10,16-18) and global Zip14 KO mice (19-
22) indicates a crucial requirement of ZIP14 in 
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systemic Mn homeostasis. ZIP14 has convincingly 
been shown to mediate hepatobiliary Mn excretion 
in concert with ZnT10 (20). However, in contrast to 
the global Zip14 KO mice, liver-specific Zip14 KO 
mice do not hyperaccumulate Mn (19), indicating 
that ZIP14 is involved in extrahepatic processes 
required for the maintenance of systemic Mn 
homeostasis.  
In the present study, we identified ZIP14 as the 
primary transporter mediating efficient Mn uptake 
from the basolateral side of enterocytes. This 
function of ZIP14 is consistent with its localization 
in the intestine and CaCo-2 monolayers (21,31), 
and the reported pH dependencies of ZIP14-
mediated Fe and Zn uptake (33,34). Our results also 
indicate that CaCo-2 cells possess alternative 
systems to acquire Mn from the basolateral 
compartment that become evident in CaCo2DZIP14 
cultures, however, due to the low capacity, these 
mechanisms are unlikely to compensate for the loss 
of ZIP14 function in vivo.  
Apical Mn uptake does not differ substantially 
in CaCo-2WT and CaCo2DZIP14 cultures, but ZIP14 
inactivation strongly enhances the flux of Mn in the 
absorptive direction, suggesting that functional 
ZIP14 is required to limit Mn absorption. 
Mechanistically, we demonstrate that inhibiting 
ZIP14-mediated basolateral Mn uptake by lowering 
the basolateral pH, Zn competition, and chelation 
of freshly absorbed Mn all increases Mn transport 
in the absorptive direction. These observations 
strongly support that intestinal ZIP14 contributes to 
the maintenance of systemic Mn homeostasis by 
restricting dietary Mn absorption via direct 
reuptake of freshly absorbed Mn. Such function of 
intestinal ZIP14 would not only explain the Mn 
hyperaccumulation observed in individuals lacking 
functional ZIP14 but also the lack of Mn 
accumulation in the liver-specific Zip14 KO mice. 
Providing evidence that ZIP14 restricts dietary 
Mn absorption in vivo, intestine-specific Zip14 KO 
mice display elevated Mn contents in the liver and 
brain, indicating that enterocyte specific KO of 
Zip14 causes Mn overload. However, these mice do 
not develop increased blood Mn concentrations at 
three weeks of age since the liver control system is 
still in place and excess Mn is likely to be cleared 
from the blood by extrahepatic tissues, including 
the brain.  
In summary, we show that ZIP14 is crucial for 
efficient Mn uptake from the basolateral membrane 
of enterocytes. We provide evidence that one 
potential mechanism by which ZIP14 restricts Mn 
absorption and limits whole body Mn burden is 
through direct reuptake of freshly absorbed Mn. 
Moreover, our in vivo data provides strong evidence 
that intestinal ZIP14 plays an important role in 
maintaining systemic Mn homeostasis.  
Experimental procedures 
Cell cultures. CaCo-2 (ATCC HTB-37TM) cells 
were maintained in growth medium [80% DMEM 
containing 1 mM pyruvate (Corning, Corning, NY, 
USA)] supplemented with 3.7 g x L-1 NaHCO3, 1x 
non-essential amino acids (Thermo Fisher 
Scientific, Waltham, MA, USA), 100 units x mL-1 
penicillin, 100 µg x mL-1 streptomycin (Thermo 
Fisher Scientific) and 20% fetal bovine serum 
(VWR, Radnor, PA, USA) at 37°C and 5% CO2 in 
the humified atmosphere of an incubator. The Mn 
concentration of the growth medium was 
determined to be 0.056 ± 0.005 µM by ICP-MS as 
described in the section ICP-MS analysis of metals 
(Fig. S7). The cells were split every three to four 
days following detachment by treatment with 
0.25% trypsin in phosphate-buffered saline (PBS) 
without calcium and magnesium and containing 
0.2% EDTA (Thermo Fisher Scientific). For 
routine cell culture the cells were seeded in cell 
culture dishes of 55 cm2 (Thermo Fisher Scientific) 
at a density of 0.1 x 104 (CaCo-2WT) or 0.14 x 104 
(CaCo2DZIP14) cells per cm2. For preparation of 
CaCo-2 cell monolayers 1 x 105 cells per cm2 were 
seeded in Transwell-ClearTM inserts with 0.4 µm 
pore size of 4.67 cm2 or 1.12 cm2 surface area (both 
from Corning) that had been incubated with growth 
medium for 24 h prior to seeding. Inserts of 4.67 
(1.12) cm2 were placed in 6-well (12-well) plates 
with 2.6 (1.5) mL of growth medium in the well and 
1.5 (0.5) mL in the insert. The growth medium was 
changed every two to three days. CaCo-2 cell 
monolayers were used for experiments between 21-
27 days after seeding. 
Generation of a CaCo-2 ZIP14 KO cell line. 
The CaCo-2 ZIP14 KO cell line was generated 
using the CRISPR-Cas9 system (49). The guide 
RNA sequence (5′-GTG CAG CAG CAG CAG 
CTT CA-3′), complementary to a sequence in 
proximity to the start codon of the ZIP14 gene, was 
cloned into the pX330-U6-Chimeric_BB-CBh-
hSpCas9 vector (50). CaCo-2 cells were transfected 
with ZIP14-targeting vector using LipofectamineTM 
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3000 (Thermo Fisher Scientific). Briefly, on the 
day of the transfection CaCo-2 cells were seeded in 
12-well plates (Thermo Fisher Scientific) at a 
density of 0.2 x 104 cell per cm2 and incubated for 
6 h in growth medium without penicillin and 
streptomycin. The medium was changed to growth 
medium and the DNA-lipid complex (1 µg plasmid 
DNA, 2 µL P3000TM reagent, 3 µL 
LipofectamineTM 3000 reagent, 95 µL DMEM),  
prepared 3 h in advance according to the protocol 
provided by the manufacturer, was added dropwise 
to the cells. The cells were grown for 72 h after 
which the medium was changed to growth medium 
containing 7.5 µg x mL-1 puromycine for selection. 
After 48 h the cells contained in one well were split 
into four culture dishes of 55 cm2 and cultured for 
three weeks in growth medium. Single-cell clones 
were transferred to 12-well plates for screening by 
immunoblot analysis with a human ZIP14-specific 
antibody described in the section Antibodies. Cell 
clones lacking ZIP14 expression were subcloned. 
ZIP14 inactivation in selected subclones was 
confirmed by immunoblot analysis and DNA 
sequencing. 
Animals. All mice were maintained on a NIH-
31 irradiated traditional rodent diet (Teklad 7913; 
Envigo, Indianapolis, IN, USA) and housed in the 
Laboratory Animal facility at the University of 
Arizona. Procedures for animal experiments were 
approved by the Institutional Animal Care and Use 
Committee. Mice carrying Zip14 conditional alleles 
(Zip14flox/flox mice) were generated by flanking exon 
3 and 4 of Zip14 gene with loxP sites (Cyagen, 
Santa Clara, CA). The transgenic mice expressing 
Cre recombinase under the intestine-specific villin 
promotor (Vil-Cre mice) and liver-specific albumin 
promoter (Alb-Cre mice) were purchased from the 
Jackson Laboratory. All mice are on the C57BL/6 
background. Genotyping procedures were 
performed by using mouse tail snipping and Mouse 
Direct PCR kit (Bimake, TX, USA). Mice were 
sacrificed after anaesthetizing with 
ketamine/xylazine at three weeks of age. Tissues 
were collected and immediately frozen in liquid 
nitrogen and stored at -80°C until further analyses.  
Antibodies. Since antibodies against mouse 
ZIP14 (mZIP14) and human ZIP14 (hZIP14) are 
not commercially available, we employed the 
approach of expressing glutathione S-transferase 
(GST) fusion proteins in E. Coli to produce and 
purify the immunogens for the production of 
antibodies. To construct a vector carrying mZIP14 
or hZIP14 fusion protein, the sequence encoding N-
terminal serine 31 to proline 146 of mZIP14, or 
serine 32 to proline 148 of hZIP14 was PCR 
amplified and cloned into pGEX-3X (Addgene, 
Watertown, MA, USA) vector using BamHI-
ECoRI linkers. The fusion protein was isolated 
from E. Coli and purified by affinity 
chromatography on Gluthathione-Sepharose 4B 
(GE Healthcare, Chicago, IL, USA). The 
immunization procedures were performed by the 
Pocono Rabbit Farm & Laboratory (Canadensis, 
PA, USA). The antisera obtained from the test 
bleeds were analyzed for ZIP14 recognition by 
immunoblotting. Antisera were cleared by 
Glutathione Sepharose cross-linked with GST to 
remove anti-GST antibody. The cleared flow-
through fractions were collected and used to purify 
anti-hZIP14 or anti-mZIP14 antibody using 
Glutathione Sepharose cross-linked with GST-
mZIP14 or GST-hZIP14 fusion protein (Fig. S8). 
The rabbit anti-ZO-1 polyclonal antibody 
(21773-1-AP), rabbit anti-DMT1 polyclonal 
antibody (20507-1-AP), horseradish peroxidase 
(HRP)-conjugated mouse anti-beta ACTIN 
monoclonal antibody (HRP-60008), HRP-
conjugated mouse anti-GAPDH monoclonal 
antibody (HRP-60004), and HRP-conjugated goat 
anti mouse IgG (H+L) secondary antibody 
(SA00001-1) were from Proteintech (Rosemont, 
IL, USA). The monoclonal mouse anti-Na+, K+-
ATPase α1 antibody (sc-21712) was from Santa 
Cruz (Dallas, TX, USA). HRP-conjugated goat 
anti-rabbit IgG (H+L) secondary antibody (65-
6120), Alexa Fluor 594-conjugated donkey anti-
mouse IgG (H+L) secondary antibody (A21203) 
and Alexa Fluor 488-conjugated goat anti-rabbit 
(A21206) secondary antibody were from Thermo 
Fisher Scientific. 
Immunoblot analysis. Cells and mouse tissues 
were lysed in NETT buffer [150 mM NaCl, 5 mM 
EDTA, 10 mM Tris, 1% Triton X-100 and 1x 
protease inhibitor cocktail (Bimake, Houston, TX, 
USA), pH 7.4]. Nuclei were removed by 
centrifugation (15000 x g / 4°C / 15 minutes). 
Protein concentrations of cell lysates were 
determined using the RC DCTM Protein Assay (Bio-
Rad Life Science, Hercules CA, USA). Cell lysates 
were mixed with 1x Laemmli buffer and incubated 
for 30 min at 37 °C. Proteins were separated 
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electrophoretically on an SDS/10% polyacrylamide 
gel and transferred to nitrocellulose membranes 
(GVS, Sanford, ME, USA). Following blocking of 
unspecific binding sites with 5% (w/v) non-fat dry 
milk in Tris-buffered saline with Tween-20 [TBS-
T; 10 mM Tris/HCl, 150 mM NaCl, 0.1% (v/v), 1 
mL Tween-20, pH 7.5], membranes were probed at 
4 °C overnight with rabbit anti-hZIP14 (1:3000), 
anti-mZIP14, or anti-DMT1 (1:5000) antibodies in 
blocking buffer. The membranes were washed four 
times with TBS-T (5 min each) and subsequently 
incubated for 1 h at room temperature (RT) with 
HRP-conjugated goat anti-rabbit secondary 
antibodies (1:5000). After two washes with TBS-T 
and TBS (5 min each), blots were developed using 
enhanced chemiluminescence (SuperSignal West 
Pico, Thermo Fisher Scientific) and the 
ChemiDoc™ MP Imaging System (Bio-Rad Life 
Science). To confirm equivalent loading, blots were 
stripped for 15 min in Restore PLUS Western Blot 
Stripping Buffer (Thermo Fisher Scientific), 
blocked for 1 h in blocking buffer, and reprobed 
with HRP-conjugated antibodies directed against 
GAPDH (1:20000) and/or b-ACTIN (1:20000) 
and. Mouse anti-Na+, K+ ATPase (1:3000) followed 
by HRP-conjugated secondary antibodies (1:5000) 
served as loading control for plasma membrane 
proteins. Blots were visualized and quantified using 
the ChemiDoc MP imaging system with Image Lab 
software (Bio-Rad). 
Isolation of genomic DNA, PCR & Sequencing. 
Genomic DNA was isolated using the Quick-
DNA™ Miniprep Plus Kit (Zymo Research, Irvine, 
CA, USA) according to the protocol provided by 
the manufacturer.  The guide RNA targeting region 
in exon 2 of the ZIP14 gene was amplified with 
DNA-specific primers (forward primer, 5′-GAG 
CAG AGA AGC AGA GAC TGA-3′; reverse 
primer, 5′- ACG GTA AGG CTC CCC TGT-3′). 
PCR products were isolated by agarose gel 
electrophoresis and purified with the Wizard SV 
Gel and PCR Clean-Up System (Promega 
Corporation, Madison, WI, USA). The purified 
PCR products were sent for sequencing to MCLAB, 
San Francisco, CA, USA.  
ICP-MS analysis of metals. CaCo-2 cell 
monolayers grown on Transwell inserts were 
washed twice with PBS, after which membranes 
were excised with a scalpel, transferred to 1.5 mL 
reaction tubes and frozen in liquid nitrogen. Cells 
were lysed by repeated freeze-thaw in 1 mL MilliQ-
water and an aliquot of 25 µL was used to determine 
the cellular protein content according to the Lowry 
method (51) using BSA as a standard. An aliquot of 
850 µL of the cell lysate was incubated with 300 µL 
HNO3 (67-70%; BDH ARISTAR PLUS, VWR) at 
85°C overnight followed by 2 h at 95°C and diluted 
to 7 mL with MilliQ-water. For the determination 
of the metal content in media, 10 mL of media were 
digested with 450 µL HNO3. The digested samples 
and mice tissues were sent for ICP-MS analysis to 
the Arizona Laboratory for Emerging 
Contaminants (ALEC, Tucson, AZ, USA). 
Immunocytochemistry & Confocal microscopy. 
CaCo-2 cell monolayers grown on Transwell 
inserts were washed twice with 2.6 mL (basolateral 
compartment) and 1.5 mL (apical compartment) 
ice-cold PBSCa/Mg (PBS supplemented with 0.5 mM 
MgCl2 and 0.9 mM CaCl2, pH 7.2) and 
subsequently fixed with methanol for 15 min at -20 
°C. After adding acetone (prechilled to -20 °C) for 
30 s, cells were washed thrice (5 min each) with 
PBSCa/Mg. The membranes were excised with a 
scalpel, transferred to fresh 6-well plates and 
blocked with 1% BSA in PBSCa/Mg for 2 h at RT. If 
not stated otherwise, the cells were washed thrice 
with PBSCa/Mg in 5 min intervals between the 
different steps of the following staining procedure. 
Incubation of the membranes with rabbit anti-ZO1 
(1:100) and mouse anti-Na+, K+ ATPase (1:100) 
was carried out at 4 °C over night in humidified 
atmosphere followed by an incubation with Alexa 
Fluor 488-conjugated goat anti-rabbit (1:500) and 
Alexa Fluor 594-conjugated goat anti-mouse 
antibodies (1:500) in 1% BSA in PBSCa/Mg for 1 h 
at RT. To visualize the nuclei, the cells were 
exposed to 4′,6-diamidino-2-phenylindole 
dihydrochloride (DAPI, 1 µg x mL-1 in PBS) for 5 
min at RT. The membranes were mounted on glass 
slides with cells facing up in ProLong Diamond 
Antifade Mountant (Thermo Fisher Scientific). A 
coverslip was placed on top of the cells and sealed 
with nail polish. Images were captured by a Zeiss 
LSM880 Inverted Confocal Microscope with a 63x 
oil objective at the Marley Imaging Core of the 
University of Arizona (Tucson, AZ, USA). 
Integrity of the monolayer. Monolayer integrity 
of CaCo-2 cells was determined by the LY rejection 
assay. The cells were washed twice with 2.6 mL 
(basolateral compartment) and 1.5 mL (apical 
compartment) PBSCa/Mg after which the inserts were 
transfered to fresh 6-well plates. 2.6 mL prewarmed 
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(37°C) salt-based incubation buffer (145 mM NaCl, 
5.4 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 0.8 mM 
Na2HPO4, 50 mM glucose, 20 mM PIPES) adjusted 
to pH 7.4 and 1.5 mL of prewarmed (37°C) 
incubation buffer containing 12.5 mg x mL-1 LY 
(Sigma-Aldrich) adjusted to pH 6.1 were added to 
the basolateral and apical compartment, 
respectively, and the cells were incubated for 4 h at 
37°C in an incubator. An aliquot of 1 mL of 
incubation buffer was removed from the basolateral 
compartment every 60 minutes and replaced by the 
same volume of fresh incubation buffer adjusted to 
pH 7.4. At the end of the experiment the media from 
both compartments were collected. Standards 
containing 12.5 µg x mL-1 to 6.1 ng x mL-1 were 
prepared in incubation buffer adjusted to pH 7.4. 
Aliquots of 150 µL standard or sample were 
transferred into a well of a black microtiter plate 
and fluorescence was quantified using a BioTek 
Synergy 2 plate reader (BioTek Instruments Inc, 
Winooski, VT, USA). The pH of the media at the 
start and the end of the experiment was measured 
with a Sartorius pHCore pH meter (Sartorius, Lab 
Instruments GmbH & Co. KG, Goettingen, 
Germany). 
Cell surface biotinylation. Cell surface 
biotinylation was performed on CaCo-2 cell 
monolayers grown on Transwell inserts. The cells 
were washed twice with 2.6 mL (basolateral 
compartment) and 1.5 mL (apical compartment) 
PBSCa/Mg prewarmed to 37°C and twice with 
PBSCa/Mg prechilled to 4°C after which the insert 
was transferred to a fresh 6-well plate. For 
biotinylation of basolateral (apical) surface 
proteins, 1.5 mL (1 mL) of freshly prepared, ice-
cold solution containing 1 mg x mL-1 Sulfo-NHS-
SS-biotin (Thermo Fisher Scientific) in PBSCa/Mg 
was added to the basolateral (apical) compartment 
and 1 mL (1.5 mL) of ice-cold PBSCa/Mg was added 
to the apical (basolateral) compartment. The cells 
were incubated on ice in an incubator at 4°C for 30 
minutes with gentle rocking. The cells were then 
washed twice with 2.6 mL (basolateral 
compartment) and 1.5 mL (apical compartment) 
PBSCa/Mg prechilled to 4°C. The reaction was 
quenched by incubating the cells with 2.6 mL 
(basolateral compartment) and 1.5 mL (apical 
compartment) 100 mM glycine in PBSCa/Mg for 20 
minutes on ice in an incubator at 4°C with gentle 
rocking. Again the cells were washed twice with 2.6 
mL (basolateral compartment) and 1.5 mL (apical 
compartment) PBSCa/Mg prechilled to 4°C. The 
insert was transferred to a fresh 6-well plate and the 
membrane was excised with a scalpel. The cells 
were lysed in 1 mL NETT buffer and the lysate was 
transferred into 1.5-mL reaction tubes. The lysate 
was chilled on ice for 20 minutes with vortexing 
every five minutes, sonicated with 10 strikes (2 s, 
amplitude 20) of a Q55 sonicator (Qsonica L.L.C, 
Newton, CT, USA) and centrifuged (15000 x g, 
4°C, 15 min). The supernatant was transferred into 
fresh 1.5 mL reaction tubes. An aliquot of 150 µL 
(total protein) was frozen in liquid nitrogen and 
stored at -80°C for later immunoblot analysis and 
850 µL of the lysates were transferred to PierceTM 
centrifuge columns that had been preloaded with 
100 µL of Pierce™ High Capacity NeutrAvidin™ 
Agarose (both from Thermo Fisher Scientific) 
according to the manufactures protocol. The 
samples were incubated overnight at 4°C with 
slight rocking motion after which the supernatant 
was removed by centrifugation for 1 minute at RT 
and 1500 x g. The agarose beads were washed once 
with NETT containing protease inhibitor, two times 
with NETT buffer without protease inhibitor, two 
times with salt wash buffer (350 mM NaCl, 5 mM 
EDTA, 0.1% Triton X-100 in PBS, pH 7.4) and 
three times with NET buffer (150 mM NaCl, 5 mM 
EDTA, 10 mM Tris, pH 7.4). Between the 
individual washing steps the supernatant was 
removed by centrifugation for 1 minute at RT and 
1500 x g. To elute the biotinylated proteins 100 µL 
of 1x Sample buffer [1.7 % (w/v) SDS, 5% (v/v) 
glycerol, 150 mM DTT, 58 mM Tris, pH 6.8] was 
added to the agarose beads and the samples were 
incubated at 4°C overnight. On the next day the 
centifuge columns were placed in fresh 1.5 mL 
reaction tubes, incubated for 30 minutes at 37°C 
and centrifuged for 2 minutes at RT and 1500 x g. 
The eluate (surface protein) was transferred to fresh 
1.5 mL reaction tubes, frozen in liquid nitrogen and 
stored at -80°C for later immunoblot analysis. 
Preparation of radiolabeled metal solutions. 
Radiolabeled metal solutions were prepared on the 
day of the experiment. Five-times concentrated (0.5 
µM) radiolabeled Mn solutions were prepared from 
54MnCl2 (PerkinElmer Inc., Waltham, MA, USA) 
complexed to citrate prior to addition to DMEM. 
Five-times concentrated (5 µM) radiolabeled Fe(II) 
solutions were prepared from 59FeCl3 (PerkinElmer 
Inc.) that had been reduced by 5 mM ascorbate prior 
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to addition to DMEM containing 5 mM ascorbate. 
Five-times concentrated (5 µM) radiolabeled 
Fe(III) solutions were prepared from 59FeCl3 that 
had been complexed to citrate prior to addition to 
DMEM. 
Metal uptake and transport. Metal uptake and 
transport was studied in CaCo-2 cell monolayers 
grown on Transwell inserts. During the 
experiments cells were incubated at 37°C in the 
humified atmosphere of an incubator and all 
solutions required before the termination of the 
experiment were prewarmed to 37°C. At the start of 
the experiments cells were washed twice with 2.6 
mL (basolateral compartment) and 1.5 mL (apical 
compartment) PBSCa/Mg. The inserts were then 
transferred to fresh 6-well plates. If not stated 
otherwise, 2.6 mL transport medium (DMEM 
containing 1 mM pyruvate supplemented with 20 
mM PIPES) adjusted to pH 7.4 and 1.5 mL tranport 
medium adjusted to pH 6.1 were added to the 
basolateral and apical compartment, respectively, 
and the cells were preincubated for 30 minutes. 
Basolateral (apical) metal uptake and basolateral-
to-apical (apical-to-basolateral) transport 
experiments were initiated by replacing 520 µL 
(300 µL) transport medium of the basolateral 
(apical) compartment by the same volume of a 
freshly prepared five-times concentrated 
radiolabeled metal solution and the cells were 
incubated for the desired times. When basolateral-
to-apical (apical-to-basolateral) transport was 
studied an aliquot of 1 mL of medium was removed 
from the apical (basolateral) compartment for g-
counting by a 2480 WIZARD2 Automatic Gamma 
Counter (PerkinElmer Inc.) and replaced by the 
same volume of the media initially added to the 
compartment at the time points indicated in the 
figures. The experiments were stopped by 
aspirating the media from both compartments and 
washing the cells three times with ice-cold PBS 
supplemented with 1 mM EDTA. The cells were 
lysed in 1 mL 0.5 M NaOH and an aliquot of 25 µL 
was used to determine the cellular protein content 
according to the Lowry method (51) using BSA as 
a standard. An aliquot of 200 µL to 800 µL of the 
lysate were used to quantify the cellular contents of 
54Mn and 59Fe by g-counting. 
Statistical analysis. Significance of differences 
between two sets of data were analyzed using 
Student’s t-test. Comparisons between multiple sets 
of data were performed using one- or two-way 
analysis of variance (ANOVA) followed by the 
Bonferroni post-hoc test, with *p < 0.05, **p < 0.01 
and ***p < 0.001. p > 0.05 was considered as not 
significant. The PRISM 5 software (GraphPad, La 
Jolla, CA, USA) was used for statistical analysis. 
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Figure 1. Generation of a ZIP14 KO CaCo-2 cell line (CaCo-2DZIP14). (A) Schematic illustration of 
CRISPR/Cas9-mediated genome editing to generate CaCo-2DZIP14 cells. The DNA sequence covering the 
start codon of ZIP14 within exon 2 is shown. The guide RNA (gRNA) sequence is marked in red letters 
and the PAM (protospacer adjacent motif) sequence is underlined in blue. The red arrow marks the 
predicted Cas9 cleavage site. (B) Chromatograms of sequencing results using DNA isolated from CaCo-
2WT and CaCo-2DZIP14 cells. The black arrow indicates the insertion of an adenosine at the predicted Cas9 
cleavage site. (C) The single adenosine-insertion results in a frameshift with premature translation 
termination after amino acid 26. (D) ZIP14 immunoblot of whole-cell lysates of CaCo-2WT (WT) and CaCo-
2DZIP14 (DZIP14) cells confirms the deletion of ZIP14 in CaCo-2DZIP14 cells. Both b-ACTIN and GAPDH 
were used as loading controls. 




Figure 2. Characterization of CaCo-2WT and CaCo-2DZIP14 transwell cultures. (A) Confocal microscopy of 
CaCo-2WT and CaCo-2DZIP14 cells co-immunostained for Na+, K+-ATPase and ZO-1. Nuclei were stained 
with DAPI. The four upper panels show the orthogonal maximum projections of 42- and 69-frames stacks 
for CaCo-2WT and CaCo-2DZIP14 cells, respectively. The two bottom panels show a perpendicular projection 
of merged Na+, K+-ATPase (red) and ZO-1 (green) proteins with nuclei (blue). The scale bars (50 µm) in 
the upper panels also apply to the bottom panels (B) Total protein content, (C) apparent permeability (Papp) 
of Lucifer Yellow and (D) specific contents of Mn, Zn, Fe and Cu of CaCo-2WT (WT) and CaCo-2DZIP14 
(DZIP14) transwell cultures. Data are presented as means ± s.d. from (B, C) 13 or (D) 3 independent 
prepared cultures. Statistical analysis was performed using Student’s t-test with **p < 0.01 and ***p < 
0.001. (E) CaCo-2WT transwell cultures were subjected to basolateral or apical surface biotinylation with 
cell membrane impermeable Sulfo-NHS-SS-biotin. Biotin-labeled cell-surface proteins (Surface) were 
isolated from whole-cell lysates (Total) using NeutrAvidin agarose beads. 45 µg whole-cell lysates (Total) 
and 15 µg Biotin-labeled cell-surface proteins (Surface) were analyzed by immunoblotting for ZIP14. Na+, 
K+-ATPase served as the basolateral marker and DMT1 as the apical marker. 
 




Figure 3. Mn uptake by CaCo-2WT and CaCo-2DZIP14 monolayers. Uptake experiments were initiated by 
adding Mn-citrate spiked with 54Mn either to the (A, B) basolateral or (C, D) apical compartment. (A, C). 
Time-dependence of Mn uptake by CaCo-2WT (WT) and CaCo-2DZIP14 (DZIP14) cells in the presence of 0.1 
µM 54Mn-citrate. During the uptake experiments the extracellular pH was maintained at pH 7.4 in the 
basolateral and pH 6.1 in the apical compartment. (B, D) pH-dependence of Mn uptake by WT and DZIP14 
cells. The cells were incubated for four hours in the presence of 0.1 µM 54Mn-citrate. During the 
experiments the pH of both the apical and basolateral compartment was maintained at the pH indicated in 
the figures. Data are presented as means ± s.d. from three independent experiments performed in duplicates. 
Statistical analysis was performed using two-way ANOVA followed by the Bonferroni post-hoc test with 
*p < 0.05, **p < 0.01 and ***p < 0.001. 
  




Figure 4. Mn transport by CaCo-2WT and CaCo-2DZIP14 monolayers. Mn-transport experiments were 
initiated by adding 0.1 µM 54Mn-citrate either to the (A) basolateral or (B) apical compartment of CaCo-
2WT (WT) and CaCo-2DZIP14 (DZIP14) monolayers. Samples were collected every 30 min from the opposite 
compartment and analyzed by g-counting. During the transport experiments the extracellular pH was 
maintained at pH 7.4 in the basolateral and pH 6.1 in the apical compartment. Data are presented as means 
± s.d. from three independent experiments performed in duplicates. Statistical analysis was performed using 
two-way ANOVA followed by the Bonferroni post-hoc test with ***p < 0.001. 
  




Figure 5. Modulation of apical to basolateral Mn transport by extracellular pH. Mn-transport experiments 
were initiated by adding 0.1 µM 54Mn-citrate to the apical compartment of (A, C, E) CaCo-2WT and (B, D, 
F) CaCo-2DZIP14 monolayers. Throughout the transport experiments the extracellular pH in the apical 
compartment was maintained at pH 6.1. (A, B) The cells were incubated for 240 minutes maintaining the 
basolateral pH at either pH 7.4 or pH 6.1. Samples were collected between 120 and 240 minutes for g-
counting. (C - F) The cells were loaded for 240 minutes with 0.1 µM 54Mn-citrate from the apical side with 
the basolateral pH maintained at (C, D) pH 7.4 or (E, F) pH 6.1. Subsequently 54Mn was removed, the cells 
were washed thrice with PBSCa/Mg from both sides and transferred to fresh 6-well plates. The accumulation 
of 54Mn in the basolateral compartment was followed for another 180 minutes, with the pH of the basolateral 
compartment either maintained at pH 7.4 or at pH 6.1. Data are presented as means ± s.d. from three 
independent experiments. Statistical analysis was performed using two-way ANOVA followed by the 
Bonferroni post-hoc test with *p < 0.05, **p < 0.01 and ***p < 0.001. 
  




Figure 6. Modulation of apical to basolateral Mn transport by Zn competition or chelators. Mn-transport 
experiments were initiated by adding 0.1 µM 54Mn-citrate to the apical compartment of (A, C, E) CaCo-
2WT and (B, D, F)) CaCo-2DZIP14 monolayers. Throughout the transport experiments the extracellular pH in 
the apical compartment was maintained at pH 6.1. The cells were loaded for 240 minutes with 0.1 µM 
54Mn-citrate from the apical side with the basolateral pH maintained at pH 7.4. Subsequently 54Mn was 
removed, the cells were washed thrice with PBSCa/Mg from both sides and transferred to fresh 6-well plates. 
The basolateral medium was changed from DMEM to salt-based incubation buffer adjusted to pH 7.4 
(control) containing (A, B) 2 µM ZnCl2, (C, D) 100 µM CaNa2EDTA or (E, F) 1 mM desferrioxamine 
(DFO) and the accumulation of 54Mn in the basolateral compartment was followed for another 90 minutes. 
Data are presented as means ± s.d. from three independent experiments. Statistical analysis was performed 
using two-way ANOVA followed by the Bonferroni post-hoc test with *p < 0.05, **p < 0.01 and ***p < 
0.001. 
  




Figure 7: Intestine-specific deletion of Zip14 in mice leads to Mn overload. (A) Gene targeting strategy for 
generating mice carrying Zip14 conditional alleles. (B) Genotyping results using DNA isolated from 
heterozygous (Flox/-), homozygous (Flox/Flox) and wild-type (-/-) mice. (C) ZIP14 immunoblot of small 
intestine and liver samples from Zip14flox/flox (n=5, 3 male and 2 female), intestine-specific (Zip14I-KO, n=6, 
3 male and 3 female) and liver-specific (Zip14L-KO, n=5, 3 male and 2 female) Zip14 KO mice. Both b-
ACTIN and GAPDH were used as loading controls. (D) Levels of Mn in livers, blood and brains of three-
week-old Zip14flox/flox, Zip14I-KO and Zip14L-KO mice. Statistical analysis was performed using one-way 
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Figure S3. Fe accumulation and Fe transport by CaCo-2WT and CaCo-2ZIP14 monolayers. CaCo-2WT (WT) 
and CaCo-2ZIP14 (ZIP14) monolayers were incubated for 5 minutes with either 1 M Fe(II)-ascorbate or 
Fe(III)-citrate spiked with 0.1 M 59Fe added to the (A) basolateral or (B) apical compartment to examine 
iron uptake. Apical-to-basolateral Fe transport experiments were initiated by adding either 1 M (C) Fe(II)-
ascorbate or (D) Fe(III)-citrate spiked with 0.1 M 59Fe to the apical compartment of CaCo-2WT (WT) and 
CaCo-2ZIP14 (ZIP14) monolayers and samples were collected every 30 minutes from the basolateral 
compartment and analyzed by -counting. During the accumulation and transport experiments the 
extracellular pH was maintained at pH 7.4 in the basolateral and pH 6.1 in the apical compartment. Data 
are presented as means ± s.d. from three independent experiments performed in duplicates. Statistical 




Figure S4. Zn competition for basolateral Mn-uptake by CaCo-2WT monolayers. The cells were incubated 
for five minutes with 0.1 M 54Mn-citrate and either 0, 1 or 2 M ZnCl2 added to the basolateral 
compartment. Zn-competition experiments were carried out using either (A) transport medium (DMEM 
containing 1 mM pyruvate supplemented with 20 mM PIPES) or (B) salt-based incubation buffer as the 
basolateral medium. Transport medium was used as the apical medium. During the experiments the 
extracellular pH was maintained at 7.4 in the basolateral and pH 6.1 in the apical compartment. Data are 
presented as means ± s.d. from (A) five or (B) three independent experiments. Statistical analysis was 









Figure S6. pH-dependent Mn transport by CaCo-2WT (WT) and CaCo-2ZIP14 (ZIP14) monolayers. Mn-
transport experiments were initiated by adding 0.1 M 54Mn-citrate either to the (A, C, E) basolateral or (B, 
D, F) apical compartment of WT and ZIP14 monolayers. Samples were collected every 30 min from the 
opposite compartment and analyzed by -counting. During the transport experiments the extracellular pH 
was maintained at (A, B) 7.4, (C, D) 6.8 or (E, F) 6.1 in both the basolateral and apical compartment. Data 
are presented as means ± s.d. from three independent experiments performed in duplicates. Statistical 
analysis was performed using two-way ANOVA followed by the Bonferroni post-hoc test with *p < 0.05, 




Figure S7. Concentrations of Mn, Fe, Zn and Cu in (A) growth medium (80% Dulbecco’s modified Eagles 
medium (DMEM) containing 1 mM pyruvate supplemented with 3.7 g/L NaHCO3, 1x non-essential amino 
acids, 100 units x mL-1 penicillin, 100 g x mL-1 streptomycin, and 20% fetal bovine serum and (B) 
transport medium (DMEM containing 1 mM pyruvate supplemented with 20 mM PIPES) adjusted to either 
pH 7.4 or pH 6.1. Metal concentrations in the media were determined by inductively coupled plasma mass 
spectrometry at the Arizona Laboratory for Emerging Contaminants (ALEC), Tucson, AZ, USA. Data are 





Figure S8. To confirm the specificity of (A) anti-hZIP14 and (B) mZIP14 antibodies, we transfected 
HEK293 cells with an empty vector (CON), a vector encoding hZIP14 with a FLAG epitope (hZIP14-
FLAG), or a vector encoding mZIP14 with a FLAG epitope (mZIP14-FLAG). Cells were lysed 48 hours 
after transfection and lysates were analyzed by immunoblotting (IB) with anti-FLAG, anti-hZIP14 or anti-
mZIP14 antibodies. The predicted molecular weights of hZIP14 and mZIP14 are 54 kDa, the 
immunoreactive band around 150 kDa represents a multimeric form of hZIP14. Our anti-hZIP14 and anti 
mZIP14 antibodies detect both monomeric and multimeric forms of ZIP14. (A) β-ACTIN and GAPDH or 
(B) Tubulin were used as loading controls.  
 
